Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese Government Hepatitis C Compensation Clears Final Diet Hurdle

This article was originally published in PharmAsia News

Executive Summary

Japan's Diet legislative body voted final approval of a bill that offers compensation to some of the more than 1,000 people who sued over hepatitis C infections caused by tainted blood. The government and drug makers were targets of the suits by patients, or their families in the cases of those who died as a result of receiving the blood products. The government action accepts responsibility for failing to take action to prevent the harm from spreading to others. The House of Councilors vote adding its approval of the measure passed earlier by the House was expected to clear the way for out-of-court settlements of most of the suits. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066609

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel